CWM
GILD icon

Catalyst Wealth Management’s Gilead Sciences GILD Stock Holding History

Catalyst Wealth Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-4,146
Closed -$356K – 125
2022
Q4 		$356K Buy
+4,146
New +$328K 0.34% 93

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Catalyst Wealth Management's GILD Position: Q1 2023 in Review

Catalyst Wealth Management sold out of Gilead Sciences (GILD) in Q1 2023, closing a stake of 4,146 shares — an estimated $356K sold.

Catalyst Wealth Management first reported a position in GILD in Q4 2022 and held it in 1 quarter. The position peaked at $356K in Q4 2022. 1,736 funds tracked by Wall St. Rank hold GILD as of Q1 2023.

  • Catalyst Wealth Management reported no remaining Gilead Sciences position as of Q1 2023 after selling out during the quarter.
  • Catalyst Wealth Management sold 4,146 Gilead Sciences shares in Q1 2023, an estimated $356K.
  • Catalyst Wealth Management first reported a position in Gilead Sciences in Q4 2022 and held it in 1 quarter.
  • Catalyst Wealth Management's Gilead Sciences position peaked at $356K in Q4 2022.
  • 1,736 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2023.

Based on Catalyst Wealth Management's 13F filing for Q1 2023, filed 11 Apr 2023.